Literature DB >> 4080869

Clinical correlates of readmission in a schizophrenic cohort.

T J Craig, S P Lin, M H el-Defrawi, A B Goodman.   

Abstract

A study of a cohort of 223 schizophrenic patients from a single catchment area followed up for two years after discharge from inpatient status revealed a significant association between the presence of two of 38 clinical problem categories (social withdrawal and drug abuse) and subsequent readmission. In addition, patients without social withdrawal who were readmitted showed a significantly greater use of aftercare services than those not readmitted, while, among those with social withdrawal, male patients were significantly more likely to be readmitted than female patients. Neither prior hospitalization nor the presence of affective symptoms were significantly associated with readmission. Clinical and research implications of these findings are discussed.

Entities:  

Mesh:

Year:  1985        PMID: 4080869     DOI: 10.1007/BF01064971

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  18 in total

1.  Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates.

Authors:  G E Hogarty; S C Goldberg
Journal:  Arch Gen Psychiatry       Date:  1973-01

2.  Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia.

Authors:  E Robins; S B Guze
Journal:  Am J Psychiatry       Date:  1970-01       Impact factor: 18.112

3.  Depressed patients with schizophrenic or paranoid symptoms.

Authors:  I F Brockington; R E Kendell; S Wainwright
Journal:  Psychol Med       Date:  1980-11       Impact factor: 7.723

4.  Relationship of psychiatric illness to drug abuse.

Authors:  R C Hall; S K Stickney; E R Gardner; M Perl; A F LeCann
Journal:  J Psychedelic Drugs       Date:  1979 Oct-Dec

5.  Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors.

Authors:  J S Strauss; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  1977-02

6.  Effects of diagnosis and treatment history on relapse of psychiatric patients.

Authors:  A D Pokorny; H B Kaplan; R J Lorimor
Journal:  Am J Psychiatry       Date:  1983-12       Impact factor: 18.112

Review 7.  Predicting the outcome in schizophrenia.

Authors:  R C Bland
Journal:  Can J Psychiatry       Date:  1982-02       Impact factor: 4.356

8.  Relapse of psychiatric patients in foster care.

Authors:  M W Linn; C J Klett; E M Caffey
Journal:  Am J Psychiatry       Date:  1982-06       Impact factor: 18.112

9.  Impact of DSM-III on clinical practice.

Authors:  T J Craig; A B Goodman; G Haugland
Journal:  Am J Psychiatry       Date:  1982-07       Impact factor: 18.112

10.  Schizophrenia: affect and outcome.

Authors:  T E Gift; J S Strauss; R F Kokes; D W Harder; B A Ritzler
Journal:  Am J Psychiatry       Date:  1980-05       Impact factor: 18.112

View more
  3 in total

1.  Substance use among the mentally ill: a comparison of Italian and American samples.

Authors:  A Fioritti; S Ferri; L Galassi; R Warner
Journal:  Community Ment Health J       Date:  1997-10

2.  Cost-benefit analysis of risperidone and clozapine in the treatment of schizophrenia in Israel.

Authors:  G Ginsberg; S Shani; B Lev
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

Review 3.  Integrated services for treatment of schizophrenic substance abusers: demographics, symptoms, and substance abuse patterns.

Authors:  R N Rosenthal; D J Hellerstein; C R Miner
Journal:  Psychiatr Q       Date:  1992
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.